Results 41 to 50 of about 3,083,119 (212)

Psychedelic-assisted therapy from a narrative therapy perspective: A map for practitioners

open access: yesInternational Journal of Narrative Therapy and Community Work
Psychedelic-assisted therapy is currently in its second wave and enjoying a renaissance of sorts. This article describes a narrative therapy–inspired approach to working therapeutically with psychedelics.
Christine Dennstedt
doaj   +1 more source

Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation

open access: yesFrontiers in Psychiatry, 2020
Psychedelic therapy shows promise as a novel intervention for a wide range of mental health concerns but its therapeutic action is incompletely understood.
Richard J. Zeifman   +6 more
doaj   +1 more source

Pharmacokinetics and safety of a modified‐release psilocybin formulation: A SAD Phase I trial in normal‐weight and overweight/obese participants

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to evaluate the safety, tolerability and pharmacokinetics of a novel oral modified‐release psilocybin formulation (REL‐P11) in normal‐weight and overweight/obese healthy adults and to assess its suitability for controlled, subperceptual exposure, in light of emerging evidence supporting serotonergic modulation in metabolic ...
Anna Signor   +11 more
wiley   +1 more source

How to make psychedelic-assisted therapy safer [PDF]

open access: yes
Classic serotonergic psychedelics are experiencing a clinical revival, which has also revived ethical debates about psychedelic-assisted therapy. A particular issue here is how to prepare and protect patients from the vulnerability that the psychedelic ...
Villiger, Daniel; https://orcid.org/
core   +1 more source

Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression

open access: yesPsychoactives
Rationale: Psychedelic research re-emerged from a period of suppression into the so-called psychedelic renaissance. In parallel, most media reporting has shifted from the overstatement of the risks of psychedelics to overly positive hype.
Daniel Meling   +9 more
doaj   +1 more source

Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders

open access: yesFrontiers in Psychiatry, 2022
The Swiss Federal Act on Narcotics allows for the restricted medical use of scheduled psychotropic drugs in cases of resistance to standard treatment, and preliminary evidence of efficacy of the scheduled drug for the particular condition.
Peter Oehen, Peter Gasser
doaj   +1 more source

Healing together: Results from a pilot trial of 3,4‐Methylenedioxymethamphetamine‐enhanced cognitive‐behavioral conjoint therapy for posttraumatic stress disorder

open access: yesJournal of Traumatic Stress, EarlyView.
Abstract Posttraumatic stress disorder (PTSD) disrupts individual well‐being and relationship health, particularly among veteran/military couples with heightened risks due to deployment, family reintegration, and traumatic stress. Although cognitive‐behavioral conjoint therapy (CBCT) and brief CBCT (bCBCT) have demonstrated strong efficacy in reducing ...
Leslie A. Morland   +11 more
wiley   +1 more source

Psychedelic Therapy as a Treatment for Alcoholism

open access: yes, 2021
Trina Lewis ’21Majors: PsychologyFaculty Mentor: Dr. Victoria Templer, Psychology Psychedelic therapy is a seldom studied, but promising treatment for substance abuse disorder.
Lewis, Trina
core  

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

open access: yesAddiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper   +7 more
wiley   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy